GO:2001262 positive regulation of semaphorin-plexin signaling pathway: Signaling Amplification, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2001262 describes any process that activates or increases the frequency, rate or extent of semaphorin-plexin signaling, a key axon guidance and cell repulsion pathway.
• Semaphorin-plexin signaling is positively regulated by growth factor signaling that amplifies F-actin disassembly and cellular repulsion.
• Nogo-A knockout upregulates axon guidance molecules including semaphorins and plexins, restricting neuronal growth and regeneration in the adult CNS.
• Dysregulation of semaphorin-plexin signaling is implicated in cancer, neurodegeneration, and impaired axon regeneration.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of positive regulators in this pathway.
• Targeted CRISPR library screening and bioinformatics can identify novel positive regulators of semaphorin-plexin signaling.
Description
GO:2001262, positive regulation of semaphorin-plexin signaling pathway, is a biological process term that captures any mechanism that activates or increases the frequency, rate, or extent of semaphorin-plexin signaling. Semaphorin-plexin signaling is a conserved axon guidance system that controls cytoskeletal dynamics, cell repulsion, and tissue patterning. Positive regulation of this pathway is critical for proper neural circuit formation and for restricting aberrant growth in the adult central nervous system. Researchers study this term to understand how extracellular cues and intracellular signaling cascades amplify semaphorin-plexin outputs, and how these processes go awry in disease. Because semaphorin-plexin signaling intersects with growth factor pathways and actin remodeling, positive regulators are attractive targets for therapeutic intervention in cancer and neurodegeneration. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of GO:2001262, its mechanisms, key genes, and experimental models.
positive regulation of semaphorin-plexin signaling pathway At A Glance
| GO ID | GO:2001262 |
|---|---|
| GO term | positive regulation of semaphorin-plexin signaling pathway |
| Ontology | biological_process |
| Synonym | positive regulation of semaphorin-plexin signalling pathway |
| Major function | Activates or increases the frequency, rate or extent of semaphorin-plexin signaling |
| Related pathway | Semaphorin-plexin axon guidance and cell repulsion |
| Cellular context | Growth cone collapse, F-actin disassembly, cellular repulsion |
| Disease relevance | Cancer, neurodegeneration, impaired axon regeneration |
| Experimental models | CRISPR knockout, point mutation, knock-in, overexpression |
What Is GO:2001262?
In our own words, GO:2001262 refers to any biological process that enhances semaphorin-plexin signaling, whether by increasing the frequency, rate, or extent of the signaling cascade. This includes mechanisms that amplify ligand-receptor interactions, strengthen downstream signal transduction, or promote cytoskeletal responses such as F-actin disassembly and cellular repulsion. The term is a child of positive regulation of signal transduction and is specific to the semaphorin-plexin pathway.
Why Is positive regulation of semaphorin-plexin signaling pathway Important in Cell Biology?
Positive regulation of semaphorin-plexin signaling is essential for precise wiring of the nervous system and for maintaining cellular architecture in adult tissues. Dysregulation of this process contributes to pathological states including tumor progression, where semaphorins can promote or inhibit angiogenesis and metastasis, and neurodegeneration, where altered guidance cues restrict regeneration. Understanding the positive regulators of this pathway provides mechanistic insight into how cells interpret repulsive cues and offers potential therapeutic targets for modulating axon regeneration and cancer cell motility.
• Controls axon guidance and neural circuit formation during development.
• Regulates growth cone collapse and F-actin disassembly in response to semaphorins.
• Restricts neuronal growth and regeneration in the adult CNS, as shown in Nogo-A knockout models.
• Implicated in cancer cell migration, invasion, and angiogenesis.
• Contributes to neurodegenerative disease pathology by limiting axonal regeneration.
• Provides targets for therapeutic modulation of repulsive signaling.
• Serves as a model for studying crosstalk between growth factor and guidance cue pathways.
• Enables CRISPR-based functional genomics to identify novel positive regulators.
What Happens During positive regulation of semaphorin-plexin signaling pathway?
Ligand-receptor engagement and signal initiation
In simple terms: Semaphorin ligands bind plexin receptors to start the signal.
Positive regulation begins with enhanced availability or affinity of semaphorin ligands for plexin receptors, leading to receptor dimerization and activation. Growth factor signaling can amplify this step by increasing semaphorin expression or promoting plexin clustering at the membrane.
Amplification of F-actin disassembly
In simple terms: The signal makes the cell's internal skeleton break down, causing repulsion.
Downstream of plexin activation, positive regulators amplify F-actin disassembly, a key step in growth cone collapse and cellular repulsion. Growth factor signaling has been shown to enhance this disassembly, thereby increasing the frequency and extent of repulsive responses.
Cytoskeletal reorganization and cellular repulsion
In simple terms: The cell pulls back and moves away from the signal.
Positive regulation leads to coordinated cytoskeletal reorganization that drives growth cone collapse and cellular repulsion. This process is critical for proper axon pathfinding and for restricting aberrant growth in the adult CNS.
Integration with growth factor signaling
In simple terms: Other growth signals can boost the semaphorin-plexin pathway.
Growth factor signaling pathways intersect with semaphorin-plexin signaling to positively regulate F-actin disassembly and cellular repulsion. This crosstalk ensures that repulsive cues are amplified in contexts where growth factors are present, fine-tuning cellular responses.
Modulation by axon guidance molecules in the adult CNS
In simple terms: In the adult brain, other guidance molecules can increase semaphorin-plexin signaling to block regrowth.
In the adult central nervous system, upregulation of axon guidance molecules such as semaphorins and plexins can positively regulate this pathway, restricting neuronal growth and regeneration. Nogo-A knockout mice exhibit increased expression of these guidance molecules, suggesting a compensatory mechanism that limits regeneration.
Key Genes Involved in GO:2001262 positive regulation of semaphorin-plexin signaling pathway
The following genes and proteins are central to positive regulation of semaphorin-plexin signaling, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SEMA3A | Semaphorin ligand that binds plexin receptors to initiate repulsive signaling | Key ligand for studying positive regulation and axon guidance |
| PLXNA1 | Plexin receptor for class 3 semaphorins | Receptor mediating F-actin disassembly and repulsion |
| PLXNA2 | Plexin receptor involved in axon guidance | Target for knockout studies on repulsive signaling |
| PLXNA3 | Plexin receptor family member | Potential positive regulator in neuronal and cancer cells |
| PLXNA4 | Plexin receptor implicated in CNS regeneration | Studied in Nogo-A knockout models |
| NEO1 | Neogenin, a receptor for netrins and repulsive guidance molecules | Modulates semaphorin-plexin crosstalk |
| DCC | Deleted in colorectal cancer, netrin receptor | Interacts with guidance pathways in axon regeneration |
| RGMA | Repulsive guidance molecule A | Upregulated in Nogo-A knockout, affecting guidance |
| ROCK1 | Rho-associated kinase, downstream of plexin | Mediates cytoskeletal changes in repulsion |
| ROCK2 | Rho-associated kinase, downstream effector | Positive regulator of F-actin disassembly |
| LIMK1 | Lim kinase, regulates actin dynamics | Effector of semaphorin-plexin signaling |
| CFL1 | Cofilin, actin depolymerizing factor | Directly promotes F-actin disassembly |
| CRMP2 | Collapsin response mediator protein 2 | Modulates growth cone collapse |
| GSK3B | Glycogen synthase kinase 3 beta | Regulates CRMP2 activity in repulsion |
| ARHGAP35 | Rho GTPase activating protein | Controls RhoA activity downstream of plexin |
| SRC | Non-receptor tyrosine kinase | Phosphorylates plexin and modulates signaling |
| FYN | Src family kinase | Contributes to positive regulation of repulsion |
| NRP1 | Neuropilin-1, co-receptor for semaphorins | Enhances ligand binding and signaling |
How Is positive regulation of semaphorin-plexin signaling pathway Regulated?
Positive regulation of semaphorin-plexin signaling is itself controlled by upstream growth factor pathways that amplify F-actin disassembly and cellular repulsion. In the adult CNS, Nogo-A knockout leads to upregulation of axon guidance molecules, suggesting a compensatory regulatory network that restricts neuronal growth and regeneration. These findings indicate that the pathway is subject to both positive and negative feedback from the cellular environment.
positive regulation of semaphorin-plexin signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SEMA3A | Cancer metastasis and neurodevelopmental disorders | CRISPR knockout in cancer cell lines |
| PLXNA4 | Neurodegeneration and impaired regeneration | Knockout mouse models |
| ROCK1 | Cancer cell invasion and metastasis | Point mutation knock-in in tumor cells |
| CFL1 | Metastasis and cytoskeletal disorders | Overexpression and knockout models |
| NRP1 | Angiogenesis and tumor growth | Conditional knockout in endothelial cells |
Cancer progression and metastasis
Semaphorin-plexin signaling can either promote or inhibit tumor progression depending on context, and positive regulators of this pathway influence cell migration, invasion, and angiogenesis. Amplification of F-actin disassembly and cellular repulsion by growth factor signaling may enhance metastatic potential in some cancers.
Neurodegeneration and impaired axon regeneration
In the adult central nervous system, upregulation of axon guidance molecules such as semaphorins and plexins restricts neuronal growth and regeneration. Nogo-A knockout mice show increased expression of these molecules, highlighting a role for positive regulation in limiting recovery after injury.
Neurodevelopmental disorders
Proper semaphorin-plexin signaling is required for neural circuit formation, and its positive regulation ensures accurate axon guidance. Disruption of this regulation can lead to wiring defects associated with neurodevelopmental disorders.
From positive regulation of semaphorin-plexin signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate positive regulator reduce semaphorin-plexin signaling? | CRISPR knockout cell lines |
| Does a specific phosphorylation site regulate pathway activity? | Point mutation knock-in |
| How does a disease-associated variant affect signaling? | Knock-in of mutant allele |
| Where and when is a positive regulator expressed? | Tagged knock-in for imaging |
| Does overexpression of a regulator enhance repulsion? | Overexpression cell models |
| Which genes are essential for pathway activation? | CRISPR library screening |
How to Study the positive regulation of semaphorin-plexin signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene essentiality for pathway activity | Discovery of positive regulators |
| Phosphoproteomics | Phosphorylation changes downstream of plexin | Mapping signaling events |
| Live-cell imaging | F-actin disassembly and growth cone collapse | Functional validation of regulators |
| RNA-seq | Transcriptional changes in knockout models | Identifying compensatory upregulation |
| Proximity labeling | Protein-protein interactions at the membrane | Finding plexin-associated complexes |
| Rho GTPase activity assays | RhoA/ROCK activation status | Measuring downstream signaling |
| CRISPR activation (CRISPRa) | Overexpression of candidate genes | Testing sufficiency of regulators |
| CRISPR interference (CRISPRi) | Knockdown of candidate genes | Testing necessity of regulators |
CRISPR knockout screening
Genome-wide CRISPR knockout screens can identify genes whose loss reduces or enhances semaphorin-plexin signaling, revealing positive regulators. This approach is unbiased and scalable for discovering novel pathway components.
Phosphoproteomics and interactomics
Mass spectrometry-based phosphoproteomics can map signaling events downstream of plexin activation, identifying phosphorylation sites that positively regulate the pathway. Interactomics can reveal protein complexes that amplify signaling.
Live-cell imaging of cytoskeletal dynamics
Live-cell imaging of F-actin and growth cone collapse provides direct readouts of positive regulation in real time. This method is ideal for validating candidate regulators identified by screening.
Transcriptomic profiling in knockout models
RNA-seq of Nogo-A knockout tissues has revealed upregulation of axon guidance molecules, including semaphorins and plexins, linking positive regulation to regenerative failure. Such profiling can identify compensatory changes in pathway activity.
How CRISPR Can Be Used to Study GO:2001262 positive regulation of semaphorin-plexin signaling pathway
Knockout
CRISPR knockout of candidate positive regulators, such as PLXNA4 or ROCK1, can abolish semaphorin-plexin signaling and reduce cellular repulsion. Knockout models are essential for establishing causality in pathway activation.
Point Mutation
Introducing point mutations in phosphorylation sites of plexin or downstream effectors can reveal residues critical for positive regulation. Such models help dissect signaling mechanisms at the molecular level.
Knock-in
Knock-in of disease-associated variants or tagged alleles allows precise tracking of pathway components and their regulation in vivo. This approach is valuable for modeling human genetic disorders linked to semaphorin-plexin signaling.
Overexpression
Overexpression of semaphorins or plexins can enhance pathway activity and amplify repulsive responses, providing gain-of-function models. These models are useful for testing sufficiency of individual regulators.
How EDITGENE Supports positive regulation of semaphorin-plexin signaling pathway Research
Researchers studying positive regulation of semaphorin-plexin signaling pathway-related genes often need to determine whether a candidate gene is causally involved in pathway activation or repression. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models, enabling rigorous functional validation of positive regulators in this pathway.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of semaphorin-plexin signaling pathway research.
Frequently Asked Questions About positive regulation of semaphorin-plexin signaling pathway
What is GO:2001262?
GO:2001262 is the Gene Ontology term for positive regulation of semaphorin-plexin signaling pathway, describing any process that activates or increases the frequency, rate or extent of this signaling.
What genes are involved in positive regulation of semaphorin-plexin signaling?
Key genes include SEMA3A, PLXNA1-4, NRP1, ROCK1/2, LIMK1, CFL1, and CRMP2, among others.
How is semaphorin-plexin signaling positively regulated?
Growth factor signaling can amplify F-actin disassembly and cellular repulsion, enhancing the pathway. In the adult CNS, upregulation of axon guidance molecules also positively regulates it.
What diseases are associated with dysregulated semaphorin-plexin signaling?
Cancer progression, neurodegeneration, and impaired axon regeneration are linked to altered positive regulation of this pathway.
What experimental models are used to study GO:2001262?
CRISPR knockout, point mutation knock-in, tagged knock-in, overexpression cell models, and CRISPR library screening are commonly used.
How can CRISPR screening identify positive regulators?
Genome-wide knockout or activation screens can reveal genes whose loss or gain alters semaphorin-plexin signaling output.
What is the role of F-actin disassembly in this pathway?
F-actin disassembly is a key downstream event that drives growth cone collapse and cellular repulsion, and its amplification is a hallmark of positive regulation.
Is Nogo-A involved in regulating semaphorin-plexin signaling?
Nogo-A knockout leads to upregulation of axon guidance molecules including semaphorins and plexins, suggesting a regulatory link.
What methods are used to measure positive regulation of semaphorin-plexin signaling?
Live-cell imaging of cytoskeletal dynamics, phosphoproteomics, RNA-seq, and Rho GTPase activity assays are commonly employed.
How can EDITGENE help study GO:2001262?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression models, library screening, and bioinformatics services to dissect positive regulators of this pathway.
Conclusion
GO:2001262, positive regulation of semaphorin-plexin signaling pathway, is a critical biological process that amplifies repulsive axon guidance and cytoskeletal remodeling. Its dysregulation contributes to cancer, neurodegeneration, and regenerative failure. By leveraging CRISPR-based models and functional genomics, researchers can identify and validate positive regulators, opening new avenues for therapeutic intervention. EDITGENE offers comprehensive services to accelerate this research.
References
- 1. Yoon J et al.. 2017. Amplification of F-Actin Disassembly and Cellular Repulsion by Growth Factor Signaling.. Dev Cell 42(2):117-129.e8 PMID: 28689759
- 2. Kempf A et al.. 2013. Upregulation of axon guidance molecules in the adult central nervous system of Nogo-A knockout mice restricts neuronal growth and regeneration.. Eur J Neurosci 38(11):3567-79 PMID: 24103058
